The Chinese gastrointestinal (GI) endoscopic device market includes GI endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. High demand for GI screening and intervention procedures due to the aging population and growing awareness will drive market growth. Over the 20112018 forecast period, market expansion will be fueled by procedural growth and a higher incidence of GI disease; this will result in market growth accelerating gradually over the forecast period.
Overall, the European gastrointestinal endoscopic devices market was valued at nearly 1.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.3% to reach just under 1.4 billion. The saturated nature of the European market for GI endoscopic devices will somewhat limit growth over the forecast period. Reimbursement
This Global Report Series represents iData’s entire collection of country-level reports in the Gastrointestinal (GI) Endoscopy Devices Market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2019) Europe (2019) China (2020) US Gastrointestinal
Overall, the U.S. GI endoscopic device market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.5% to exceed $3.7 billion. As the demand side of the market continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the
Industry Trends Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel. Modeled after advanced missile guidance technology, capsule endoscopy allows patients to undergo diagnostic procedures without any of the discomfort associated with conventional endoscopies. These procedures are noninvasive and typically painless. From 2001 to